Category: Consumer news

In September 2023, an FDA advisory panel unanimously concluded that the ingredient oral phenylephrine is ineffective as a nasal decongestant. This ruling triggered widespread concern and the question: "Are they pulling DayQuil off shelves?" While the DayQuil brand itself is not being discontinued, specific products containing this ingredient will be affected by future regulatory action.

Following a unanimous advisory committee vote in September 2023, the FDA officially proposed removing oral phenylephrine, found in many over-the-counter drugs, due to a lack of efficacy. This action raised a critical question for many consumers: **What is the FDA getting rid of cold medicine?** This move signals a significant change for countless cold and allergy products sold in the U.S..